Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Reader’s Guide to the Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
Filetype[PDF-36.93 KB]


Details:
No Related Documents.
You May Also Like:
  1. A new era for treatment of drug-resistant tuberculosis
    Personal Author:
    Gandhi, Neel R.; Brust, James C.M.; Shah, N. Sarita;
    Published Date:
    October 04 2018
    Source:
    Eur Respir J. 52(4)
    File Type:
    Filetype[PDF - 116.57 KB]
  2. Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
    Personal Author:
    Lienhardt, Christian; Vernon, Andrew A.; Cavaleri, Marco; Nambiar, Sumati; Nahid, Payam;
    Published Date:
    September 06 2019
    Source:
    PLoS Med. 2019; 16(9)
    Description:
    Christian Lienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.
    File Type:
    Filetype[PDF - 444.45 KB]
  3. National Action Plan for Combating Multidrug-Resistant Tuberculosis : year two report May 2018
    Corporate Authors:
    United States. Agency for International Development.. National Institute of Allergy and Infectious Diseases (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published Date:
    May 2018
    Description:
    NAP-MDR-TB-Year-Two-508.pdf
    File Type:
    Filetype[PDF - 617.78 KB]
  4. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis
    Personal Author:
    Mase, Sundari; Chorba, Terence; LoBue, Philip; Castro, Kenneth G.;
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    October 25, 2013
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-9
    Description:
    This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations, such as children, pregnant women, or persons with extrapulmonary MDR TB who were not included in the clinical t...
    Status:
    current
    File Type:
    Filetype[PDF - 420.66 KB]
  5. Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel
    Personal Author:
    Nachman, Sharon; Ahmed, Amina; Amanullah, Farhana; Becerra, Mercedes C; Botgros, Radu; Brigden, Grania; Browning, Renee; Gardiner, Elizabeth; Hafner, Richard; Hesseling, Anneke; How, Cleotilde; Jean-Philippe, Patrick; Lessem, Erica; Makhene, Mamodikoe; Mbelle, Nontombi; Marais, Ben; McIlleron, Helen; Mc Neeley, David F; Mendel, Carl; Murray, Stephen; Navarro, Eileen; Oramasionwu, Gloria E; Porcalla, Ariel R; Powell, Clydette; Powell, Mair; Rigaud, Mona; Rouzier, Vanessa; Samson, Pearl; Schaaf, H. Simon; Shah, Seema; Starke, Jeff; Swaminathan, Soumya; Wobudeya, Eric; Worrell, Carol;
    Published Date:
    May 06 2015
    Source:
    Lancet Infect Dis. 15(6):711-720.
    Description:
    Children younger than 18 years account for a substantial proportion of patients with tuberculosis worldwide. Available treatments for paediatric drug-susceptible and drug-resistant tuberculosis, albeit generally effective, are hampered by high pill b...
    File Type:
    Filetype[PDF - 1.10 MB]